Gene modified T cells expressing a chimeric antigen receptor for a kappa light chain antigen to treat multiple myeloma

Lead Researcher: Dr Kenneth Micklethwaite

Institution: University of Sydney (NSW)

Funding: $332,077

Funding Duration: 2015 - 2017

‍

The Research

Helping the immune system to target and destroy multiple myeloma cells.

‍